Traditional Risk Factors, Optimal Cardiovascular Health, and Elevated Lipoprotein(a).

IF 8.4 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS European journal of preventive cardiology Pub Date : 2024-11-28 DOI:10.1093/eurjpc/zwae382
Alexander C Razavi, Mikaila P Reyes, John T Wilkins, Moyses S Szklo, Michael Y Tsai, Seamus P Whelton, Laurence S Sperling, Sotirios Tsimikas, Harpreet S Bhatia
{"title":"Traditional Risk Factors, Optimal Cardiovascular Health, and Elevated Lipoprotein(a).","authors":"Alexander C Razavi, Mikaila P Reyes, John T Wilkins, Moyses S Szklo, Michael Y Tsai, Seamus P Whelton, Laurence S Sperling, Sotirios Tsimikas, Harpreet S Bhatia","doi":"10.1093/eurjpc/zwae382","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To assess the association of traditional risk factor burden and Life's Simple 7 (LS7) score with incident atherosclerotic cardiovascular disease (ASCVD) across Lp(a) levels.</p><p><strong>Methods: </strong>There were 6,676 participants without clinical ASCVD from the Multi-Ethnic Study of Atherosclerosis who underwent Lp(a) testing and were followed for incident ASCVD events (coronary heart disease and stroke). Low, intermediate, and elevated Lp(a) were defined as <30, 30-49, and >50 mg/dL, respectively. Cox proportional hazards regression assessed the association of traditional risk factors and LS7 score (poor: 0-8, average: 9-10, optimal: 11-14) with incident ASCVD across Lp(a) groups during a median follow-up of 17.7 years, adjusting for demographics and time-varying statin and aspirin therapy.</p><p><strong>Results: </strong>The mean age was 62.1 years, 53% were women, and 61% were non-white. The median Lp(a) was 17 (IQR 8-41) mg/dL, 13% had Lp(a) 30-49 mg/dL, and 20% had Lp(a) >50 mg/dL. Individuals with Lp(a) >50 mg/dL had higher absolute event rates across all LS7 categories. There was no significant interaction between Lp(a) and LS7 score on incident ASCVD (p-interaction=0.60). Compared to a poor LS7 score, optimal LS7 conferred a lower risk for incident ASCVD among individuals with Lp(a) <30 (HR=0.45, 95% CI: 0.28-0.71), Lp(a) 30-49 (HR=0.12, 95% CI: 0.02-0.89), and Lp(a) >50 mg/dL (HR=0.35, 95% CI: 0.13-0.99).</p><p><strong>Conclusion: </strong>Participants without clinical ASCVD who achieved an optimal LS7 score had ASCVD risk reduction regardless of Lp(a) level. These results emphasize the importance of a healthy lifestyle and ASCVD risk factor control among individuals with elevated Lp(a).</p>","PeriodicalId":12051,"journal":{"name":"European journal of preventive cardiology","volume":" ","pages":""},"PeriodicalIF":8.4000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of preventive cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurjpc/zwae382","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: To assess the association of traditional risk factor burden and Life's Simple 7 (LS7) score with incident atherosclerotic cardiovascular disease (ASCVD) across Lp(a) levels.

Methods: There were 6,676 participants without clinical ASCVD from the Multi-Ethnic Study of Atherosclerosis who underwent Lp(a) testing and were followed for incident ASCVD events (coronary heart disease and stroke). Low, intermediate, and elevated Lp(a) were defined as <30, 30-49, and >50 mg/dL, respectively. Cox proportional hazards regression assessed the association of traditional risk factors and LS7 score (poor: 0-8, average: 9-10, optimal: 11-14) with incident ASCVD across Lp(a) groups during a median follow-up of 17.7 years, adjusting for demographics and time-varying statin and aspirin therapy.

Results: The mean age was 62.1 years, 53% were women, and 61% were non-white. The median Lp(a) was 17 (IQR 8-41) mg/dL, 13% had Lp(a) 30-49 mg/dL, and 20% had Lp(a) >50 mg/dL. Individuals with Lp(a) >50 mg/dL had higher absolute event rates across all LS7 categories. There was no significant interaction between Lp(a) and LS7 score on incident ASCVD (p-interaction=0.60). Compared to a poor LS7 score, optimal LS7 conferred a lower risk for incident ASCVD among individuals with Lp(a) <30 (HR=0.45, 95% CI: 0.28-0.71), Lp(a) 30-49 (HR=0.12, 95% CI: 0.02-0.89), and Lp(a) >50 mg/dL (HR=0.35, 95% CI: 0.13-0.99).

Conclusion: Participants without clinical ASCVD who achieved an optimal LS7 score had ASCVD risk reduction regardless of Lp(a) level. These results emphasize the importance of a healthy lifestyle and ASCVD risk factor control among individuals with elevated Lp(a).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
传统风险因素、最佳心血管健康和脂蛋白(a)升高。
目的:评估不同脂蛋白(a)水平的传统风险因素负担和生命简单7(LS7)评分与动脉粥样硬化性心血管疾病(ASCVD)事件的关联:多种族动脉粥样硬化研究(Multi-Ethnic Study of Atherosclerosis)中有 6,676 名无临床 ASCVD 的参与者接受了脂蛋白(a)检测,并对他们的 ASCVD 事件(冠心病和中风)进行了随访。低、中、高脂蛋白(a)的定义分别为 50 mg/dL。Cox比例危险回归评估了在中位随访17.7年期间,传统风险因素和LS7评分(差:0-8分,平均:9-10分,最佳:11-14分)与各脂蛋白(a)组发生ASCVD事件的关系,并对人口统计学和随时间变化的他汀类药物和阿司匹林治疗进行了调整:平均年龄为 62.1 岁,53% 为女性,61% 为非白人。脂蛋白(a)中位数为 17 (IQR 8-41) mg/dL,13% 的人脂蛋白(a)为 30-49 mg/dL,20% 的人脂蛋白(a)大于 50 mg/dL。Lp(a) >50 mg/dL 的个体在所有 LS7 类别中的绝对事件发生率都较高。脂蛋白(a)和LS7评分之间在ASCVD事件发生率上没有明显的相互作用(p-interaction=0.60)。与较差的LS7评分相比,Lp(a) 50 mg/dL的个体中,最佳LS7评分可降低发生ASCVD的风险(HR=0.35,95% CI:0.13-0.99):无论脂蛋白(a)水平如何,达到最佳LS7评分且无临床ASCVD的参与者均可降低ASCVD风险。这些结果强调了在脂蛋白(a)升高的人群中,健康的生活方式和ASCVD风险因素控制的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European journal of preventive cardiology
European journal of preventive cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
12.50
自引率
12.00%
发文量
601
审稿时长
3-8 weeks
期刊介绍: European Journal of Preventive Cardiology (EJPC) is an official journal of the European Society of Cardiology (ESC) and the European Association of Preventive Cardiology (EAPC). The journal covers a wide range of scientific, clinical, and public health disciplines related to cardiovascular disease prevention, risk factor management, cardiovascular rehabilitation, population science and public health, and exercise physiology. The categories covered by the journal include classical risk factors and treatment, lifestyle risk factors, non-modifiable cardiovascular risk factors, cardiovascular conditions, concomitant pathological conditions, sport cardiology, diagnostic tests, care settings, epidemiology, pharmacology and pharmacotherapy, machine learning, and artificial intelligence.
期刊最新文献
Traditional Risk Factors, Optimal Cardiovascular Health, and Elevated Lipoprotein(a). Sex differences in myocardial infarction care and outcomes: a longitudinal Scottish National Data-Linkage Study. Albiglutide and atrial fibrillation in patients with type 2 diabetes and established cardiovascular disease - insights from the Harmony Outcomes trial. Type D Personality As a Risk Factor for 3-Year Cardiovascular Events in Patients With Coronary Artery Disease and Their Spouse: A Prospective Cohort Study. Association of Modifiable Lifestyle Risk Factors with High-Sensitivity Troponin T and I Concentrations and Clinical Outcomes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1